Small Nuclear RNA-Mediated Exon 51 Skipping AAV9 Gene Therapy for the Treatment of Duchenne Muscular Dystrophy

被引：0

作者：

Markmiller, Rea Lardelli ^{[1
]}

Nachtrab, Greg ^{[1
]}

Geddes, Claire ^{[1
]}

Tadokoro, Taka ^{[1
]}

Pasha, Sheik ^{[1
]}

Knowland, Daniel ^{[1
]}

Roth, Daniela ^{[1
]}

Carreno, Alberto ^{[1
]}

Villegas, Gustavo ^{[1
]}

Sarkar, Anindita ^{[1
]}

Reid, Derek ^{[1
]}

Nguyen, Lynn ^{[1
]}

Adams, Rachel ^{[1
]}

Diago, Oscar ^{[1
]}

Vakharia, Shruti ^{[1
]}

Almaguer, Bryan ^{[1
]}

Gutierrez, Haydee ^{[1
]}

Go, Yesol ^{[1
]}

Torres, Ronald ^{[1
]}

Narayan, Nandini ^{[1
]}

Vashist, Deepti ^{[1
]}

Berlin, Aaron ^{[1
]}

Tran, Amanda ^{[1
]}

Batra, Ranjan ^{[1
]}

Leonard, John E. ^{[1
]}

机构：

[1] Locanabio, San Diego, CA USA

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1198

引用

页码：571 / 571

页数：1

共 50 条

[31] AAV-Mediated Exon51 Skipping Results in Durable Dystrophin Protein Restoration and Correction of Histopathology in a Mouse Model for Duchenne Muscular Dystrophy
Jin, Lan
Qian, Randolph
Foltz, Steven
Chen, Ting
Elliott, Kirk W.
Yang, Jason
Danos, Olivier F.
Liu, Ye
MOLECULAR THERAPY, 2024, 32 (04) : 543 - 544
[32] Optimization of therapeutic antisense-mediated exon skipping for Duchenne muscular dystrophy
Aartsma-Rus, Annemieke
Heemskerk, Hans
De Winter, Christa
Janson, Anneke
Van Ommen, Gert-Jan
Van Deutekom, Judith
HUMAN GENE THERAPY, 2007, 18 (10) : 983 - 984
[33] Questions about efficacy of exon-skipping therapy for duchenne muscular dystrophy
Poduri, Annapurna
Salih, Mustafa
Walsh, Christopher A.
ANNALS OF NEUROLOGY, 2014, 75 (02) : 326 - 326
[34] Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy
Nakamura, Akinori
JOURNAL OF HUMAN GENETICS, 2017, 62 (10) : 871 - 876
[35] Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy
Akinori Nakamura
Journal of Human Genetics, 2017, 62 : 871 - 876
[36] Pip peptide conjugates of exon skipping PMO for therapy of Duchenne muscular dystrophy
Arzumanov, Liz O'Donovan Andrey A.
Gait, Michael J.
HUMAN GENE THERAPY, 2014, 25 (11) : A13 - A14
[37] Dual exon skipping in myostatin and dystrophin as a potential therapy for Duchenne muscular dystrophy
Kemaladewi, D. U.
Hoogaars, W. M. H.
van Heiningen, S. H.
van Deutekom, J. C. T.
den Dunnen, J. T.
van Ommen, G. J. B.
Aartsma-Rus, A. R.
ten Dijke, P.
't Hoen, P. A. C.
NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 577 - 577
[38] Optimization of Antisense Oligonucleotide Drugs for Skipping Dystrophin Exon 51 and 53 in Duchenne Muscular Dystrophy
Wu, Bo
MOLECULAR THERAPY, 2018, 26 (05) : 148 - 148
[39] Antisense-mediated Exon 51 skipping restores local dystrophin expression in muscle of Duchenne muscular dystrophy patients
van Deutekom, Judith
Janson, Anneke
Aartsma-Rus, Annemieke
Platenburg, Gerard
Verschuuren, Jan
van Ommen, Gert-Jan
HUMAN GENE THERAPY, 2007, 18 (10) : 949 - 949
[40] The significance of exons skipping therapy in the treatment of Duchenne muscular dystrophy
Takeda, Shinichi
NEUROSCIENCE RESEARCH, 2010, 68 : E53 - E53

← 1 2 3 4 5 →